Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 21356520
Song WJ, et al. (2011) Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab 13, 308-19 21356520
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S50-p - SNAPIN (human)
Modsite: HVHAVREsQVELREQ SwissProt Entrez-Gene
Orthologous residues
SNAPIN (human): S50‑p, SNAPIN (mouse): S50‑p, SNAPIN (rat): S50‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  pancreatic cancer, pancreatic carcinoma
Relevant cell lines - cell types - tissues:  INS-1 (pancreatic)
Cellular systems studied:  cell lines
Species studied:  rat
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKACA (human) transfection of wild-type enzyme, pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
exenatide increase
mPKI exenatide inhibit treatment-induced increase
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
SNAP-25 (human) Induces co-immunoprecipitation
VAMP2 (human) Induces co-immunoprecipitation
RAPGEF4 (human) Induces co-immunoprecipitation
TMEM27 (human) Induces co-immunoprecipitation
Comments:  potentiates glucose-stimulated insulin secretion (GSIS)

S50-gl - SNAPIN (human)
Modsite: HVHAVREsQVELREQ SwissProt Entrez-Gene
Orthologous residues
SNAPIN (human): S50‑gl, SNAPIN (mouse): S50‑gl, SNAPIN (rat): S50‑gl
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  pancreatic cancer, pancreatic carcinoma
Relevant cell lines - cell types - tissues:  INS-1 (pancreatic)
Cellular systems studied:  cell lines
Species studied:  rat